Jeong Y I, Ohno T, Hu Z, Yoshikawa Y, Shibata N, Nagata S, Takada K
Department of Pharmacokinetics, Kyoto Pharmaceutical University, Yamashina-ku, 607-8414, Kyoto, Japan.
J Control Release. 2001 Apr 2;71(2):175-82. doi: 10.1016/s0168-3659(01)00211-5.
A new method for preparation of large amounts of empty pressure-controlled colon delivery capsules (PCDCs) by a dipping method has been developed. Empty PCDCs are composed of two polymer membranes. The inner one was a water-insoluble polymer membrane, ethylcellulose (EC). The outer one was an enteric polymer membrane, hydroxypropylmethylcellulose phthalate (HPMCP) or hydroxypropylmethylcellulose acetate succinate (HPMCAS). By consequently dipping into an ethanolic EC solution and an alkalized enteric polymer solution, empty PCDCs were obtained after both the capsule body and cap were adjusted to the size of #2 capsules. With each enteric polymer, two types of empty PCDCs of different thickness were prepared. Fluorescein (FL) was formulated with suppository base, PEG1000, and used as a model drug. FL/PEG1000 suspension was introduced into empty PCDCs which were then sealed with enteric polymer solution. The PCDCs were evaluated by an in vivo experiment using beagle dogs. After oral administration of the test PCDC preparations containing 30 mg of FL, blood samples were obtained from the jugular vein and serum FL levels were measured. The thickness of the EC membrane layer varied in both the capsule body and cap. HPMCAS PCDCs had 62.1+/-5.0 (S.E.) microm (body) and 49.7+/-3.3 microm (cap) with thicker ones and 55.7+/-6.6 microm (body) and 46.8+/-6.2 microm (cap) with thinner ones. HPMCP PCDCs had 28.1+/-3.3 microm (body), 30.9+/-1.0 microm (cap) with thinner ones and 43.1+/-9.8 microm (body), 42.4+/-8.2 microm (cap) with thicker ones. The mean T(i) values, the first appearance time, of FL in the serum of HPMCAS PCDCs were 2.0+/-0.7 h for thicker ones and 3.8+/-0.5 h for thinner ones, while the mean T(i) values of HPMCP PCDCs were 2.0+/-0.0 h for thinner ones and 3.5+/-0.7 h for thicker ones. Since the colon arrival time in beagle dogs was 3.5+/-0.3 h as determined by a sulfasalazine test, thinner HPMCAS PCDCs and thicker HPMCP PCDCs were thought to deliver FL to the colon.
已开发出一种通过浸渍法制备大量空的压力控制结肠给药胶囊(PCDCs)的新方法。空的PCDCs由两个聚合物膜组成。内层是水不溶性聚合物膜,乙基纤维素(EC)。外层是肠溶聚合物膜,羟丙基甲基纤维素邻苯二甲酸酯(HPMCP)或羟丙基甲基纤维素乙酸琥珀酸酯(HPMCAS)。通过依次浸入乙醇EC溶液和碱化的肠溶聚合物溶液中,在将胶囊体和帽调整到2号胶囊尺寸后获得空的PCDCs。对于每种肠溶聚合物,制备了两种不同厚度的空PCDCs。将荧光素(FL)与栓剂基质聚乙二醇1000(PEG1000)配制成制剂,并用作模型药物。将FL/PEG1000悬浮液引入空的PCDCs中,然后用肠溶聚合物溶液密封。使用比格犬通过体内实验对PCDCs进行评估。口服给予含30mg FL的测试PCDC制剂后,从颈静脉采集血样并测量血清FL水平。EC膜层的厚度在胶囊体和帽中均有所不同。较厚的HPMCAS PCDCs的胶囊体厚度为62.1±5.0(标准误)μm,帽厚度为49.7±3.3μm;较薄的HPMCAS PCDCs的胶囊体厚度为55.7±6.6μm,帽厚度为46.8±6.2μm。较薄的HPMCP PCDCs的胶囊体厚度为28.1±3.3μm,帽厚度为30.9±1.0μm;较厚的HPMCP PCDCs的胶囊体厚度为43.1±9.8μm,帽厚度为42.4±8.2μm。较厚的HPMCAS PCDCs的FL在血清中的平均T(i)值(首次出现时间)为2.0±0.7小时;较薄的为3.8±0.5小时。而较薄的HPMCP PCDCs的FL平均T(i)值为2.0±0.0小时,较厚的为3.5±0.7小时。由于通过柳氮磺胺吡啶试验确定比格犬的结肠到达时间为3.5±0.3小时,因此认为较薄 的HPMCAS PCDCs和较厚的HPMCP PCDCs可将FL递送至结肠。